We’re Stronger Together
With your help, we can advance education and improve student success in our community.
Presentation
Research
- Tsai JY, Aviv H, Benevenia J, Patterson F, Aisner S, Pliner L, Hameed M. Prognostic factors in osteosarcoma – role of Her-2/neu and p53: an immunohistochemical (IHC) and fluorescence in situ hybridization (FISH) analysis. Proc Am Soc Clin Oncol 2001; 20: 295b (Abstract 2933). Oral Presentation at the New York Academy of Medicine, New York, New York, June 6, 2001. (06/2001 - Present)
- “Combined Modality Therapy for Pancreatic Cancer.” Brown University/Rhode Island Hospital, George Library, May 30, 2002 (05/2002 - Present)
- “Status Treatment for Advanced Gastric Carcinoma.” Brown University/Rhode Island Hospital, George Library, December 12, 2002. (12/2002 - Present)
- Tsai JY, Constantinou M, Khurshid H, Moore T, Rathore R, Maia C, Hughes M, Harrington D, Kennedy T, Safran H. A phase I study of capecitabine, docetaxel, and carboplatin in metastatic esophagogastric cancer. Proc Am Soc Clin Oncol 2003; 22:318 (Abstract 1276). (2003 - Present)
- “Neoadjuvant Therapy for Esophageal Cancer.” Brown University/Rhode Island Hospital, George Library, February 5, 2004. (02/2004 - Present)
- Tsai JY, Berkenblit A, Akerman P, Nadeem A, Rathore R, Harrington D, Roye D, Stuart K, Kennedy T, Safran H. Phase I/II study of docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer. Proc Am Soc Clin Oncol 2004;23:321(Abstract 4035). ASCO Merit Award. Poster Presentation. Tenth Tenth Annual Research Forum, Department of Medicine, Brown University, Providence, RI, June 10, 2004. Poster Presentation. The 2004 Gastrointestinal Oncology Conference, International Society of Gastrointestinal Oncology (ISGIO), Washington, D.C., July 8-10, 2004. Poster/Abstract Presentation. (05/2004 - Present)